To further extend the audience of vaccinated people – including very young people – to avoid even the hypothesis of a new national lockdown across the Channel. Boris Johnson outlines anti-Covid plans for autumn and winter in a country where the vaccine has already reached 81% of over 16s with two doses (90% with one). And it relies on the country’s top medical authorities – the chief medical officers of the UK’s 4 nations – to overturn the recommendation to exclude healthy children between 12 and 15 years old just a couple of weeks ago by other specialists. those of the Joint Committee on Vaccination and Immunization (Jcvi).
The details of the British winter strategy against the pandemic are entrusted to a press conference scheduled for tomorrow in Downing Street, which Prime Minister Tory will hold alongside – as a shield – Professor Patrick Vallance, Chief Scientific Advisor of the Government, and above all Professor Chris Whitty, an internationally renowned virologist and chief medical officer of England. But the views of Whitty and her counterparts in Scotland, Wales and Northern Ireland on the green light for mass administration of a single vaccine dose under the age of 16 has already been formalized today. And it opens the door to overcoming the reservations of the JCVI: which, although without questioning the efficacy and overall safety of the approved antidotes, had chosen not to recommend their use at the moment among 12-15 year olds – if not immunosuppressed. o struggling with previous chronic diseases – evoking an ad hoc margin of caution on the evaluation of the risk / benefit ratio in this specific age group.
“We are waiting to hear what the chief medical officers have to say: I think it is up to them to decide rather than to the politicians”, BoJo glissed in the morning, pressed by journalists in postponing the other details until tomorrow. The response, however, is now public in its essential points: with the ok limited for the moment to a single dose for the youngest and justified by the belief that greater immune coverage can make the school environment safer after the general reopening of the classrooms of the Kingdom in the past few weeks.
“What we want is to do everything possible to protect the country,” the premier cut short on the sidelines of a visit to Leicester. A goal that the Tory government aims to achieve by betting almost everything at this stage on a further leap forward in the vaccination campaign in order not to re-propose the specter of the lockdown; to set aside or at least postpone the imposition of the Green pass for access to public places or collective events; and not to reinstate any of the restrictions lifted in July for now. Except for reserving, in the event of a new winter spike in infections (settled in September around 30,000 per day on the island, albeit with fewer hospitalizations and much fewer deaths than previous waves), to be able to reintroduce in crowded public places or on public transport urban transport the restriction of masks (in England no longer mandatory anywhere from 19 July) or the indication of work from home in a wide range.
Johnson has meanwhile confirmed that the initiation of the administration of a third vaccination booster starting this month for the vulnerable and the elderly will go ahead “according to approved programs”. While he insisted on appealing to the remaining 10% of British adults who have not yet received the first dose to come forward, since “unfortunately there are still people dying from Covid”: almost all, he warned, “not vaccinated”.
The recommendation of the chief medical officers of the United Kingdom to the government of Boris Johnson on the green light for a first extension of the anti Covid vaccinations also to healthy children and young people between 12 and 15 years is official. The new indication – which corrects the more cautious one to vaccinate only immunosuppressed or chronically ill people under 16 initially advanced by the consultants of the British Joint Committee on Vaccination and Immunization (JCVI) – is also limited at the moment to the ok to a single dose of Pfizer vaccine. o Modern. To formalize the course correction – which the government according to the media had urged, to address fears related to the reopening of all schools – were in a briefing Chris Whitty, chief medical officer of England, his deputy Jonathan Van- Tam, the head of the UK drug regulatory agency (MHRA), June Raine, and the chief medical officers of Scotland, Wales and Northern Ireland, Gregor Smith, Frank Atherton and Michael McBride. Also present was a representative of the JCVI, Professor Wei Shen Lim. Professor Whitty spoke of “a difficult decision”, taken by adopting a sort of median way in order to try to “balance risks and benefits” in an age group in which contagions are increasing proportionally, but remain largely asymptomatic or otherwise not serious; while he denied a substantive contrast with the JCVI. He then added that it was evaluated that a dose could guarantee greater immune protection and reduce the fear of backlash in school settings, while he assured that all indications on cases of side effects attributed worldwide to Pfizer and Moderna will continue to be carefully monitored. . Cases that, for her part, Dr. Raine has also emphasized have been “very rare” so far, especially among the very young. Finally, a mechanism was established to guarantee the right to “informed consent” of young people.